99 related articles for article (PubMed ID: 35956550)
1. Isolation and In Silico Inhibitory Potential against SARS-CoV-2 RNA Polymerase of the Rare Kaempferol 3-
Suleimen YM; Jose RA; Mamytbekova GK; Suleimen RN; Ishmuratova MY; Dehaen W; Alsfouk BA; Elkaeed EB; Eissa IH; Metwaly AM
Plants (Basel); 2022 Aug; 11(15):. PubMed ID: 35956550
[TBL] [Abstract][Full Text] [Related]
2. Computer-assisted drug discovery of potential natural inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase through a multi-phase
Elkaeed EB; Alsfouk BA; Ibrahim TH; Arafa RK; Elkady H; Ibrahim IM; Eissa IH; Metwaly AM
Antivir Ther; 2023 Oct; 28(5):13596535231199838. PubMed ID: 37669909
[TBL] [Abstract][Full Text] [Related]
3. The Computational Preventive Potential of the Rare Flavonoid, Patuletin, Isolated from
Metwaly AM; Elkaeed EB; Alsfouk BA; Saleh AM; Mostafa AE; Eissa IH
Plants (Basel); 2022 Jul; 11(14):. PubMed ID: 35890520
[TBL] [Abstract][Full Text] [Related]
4. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.
Wakchaure PD; Ghosh S; Ganguly B
J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493
[TBL] [Abstract][Full Text] [Related]
5. Jusanin, a New Flavonoid from
Suleimen YM; Jose RA; Suleimen RN; Arenz C; Ishmuratova MY; Toppet S; Dehaen W; Alsfouk BA; Elkaeed EB; Eissa IH; Metwaly AM
Molecules; 2022 Mar; 27(5):. PubMed ID: 35268738
[TBL] [Abstract][Full Text] [Related]
6. Isolation and In Silico Anti-SARS-CoV-2 Papain-Like Protease Potentialities of Two Rare 2-Phenoxychromone Derivatives from
Suleimen YM; Jose RA; Suleimen RN; Arenz C; Ishmuratova M; Toppet S; Dehaen W; Alsfouk AA; Elkaeed EB; Eissa IH; Metwaly AM
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209006
[TBL] [Abstract][Full Text] [Related]
7.
Pandey K; Lokhande KB; Swamy KV; Nagar S; Dake M
Bioinform Biol Insights; 2021; 15():11779322211027403. PubMed ID: 34248355
[TBL] [Abstract][Full Text] [Related]
8. Drummondin E and Flinderole B are potential inhibitors of RNA-dependent RNA polymerase of SARS-CoV-2: an
Akhtar N; Verma H; Silkari OM; Upadhyay AK; Kaushik V; Mannan MA
BioTechnologia (Pozn); 2022; 103(1):53-70. PubMed ID: 36605381
[TBL] [Abstract][Full Text] [Related]
9. The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach.
Elkaeed EB; Khalifa MM; Alsfouk BA; Alsfouk AA; El-Attar AMM; Eissa IH; Metwaly AM
Metabolites; 2022 Nov; 12(11):. PubMed ID: 36422263
[TBL] [Abstract][Full Text] [Related]
10. Isolation and
Wanas AS; Radwan MM; Marzouk AA; Elkaeed EB; Alsfouk BA; Mostafa AE; Eissa IH; Metwaly AM; ElSohly MA
Nat Prod Res; 2023 Dec; ():1-14. PubMed ID: 38100380
[TBL] [Abstract][Full Text] [Related]
11. Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective.
Sonousi A; Mahran HA; Ibrahim IM; Ibrahim MN; Elfiky AA; Elshemey WM
Pharmacol Rep; 2021 Dec; 73(6):1754-1764. PubMed ID: 34165771
[TBL] [Abstract][Full Text] [Related]
12. Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase.
Zhang L; Zhou R
J Phys Chem B; 2020 Aug; 124(32):6955-6962. PubMed ID: 32521159
[TBL] [Abstract][Full Text] [Related]
13. Facilitating SARS CoV-2 RNA-Dependent RNA polymerase (RdRp) drug discovery by the aid of HCV NS5B palm subdomain binders: In silico approaches and benchmarking.
Elghoneimy LK; Ismail MI; Boeckler FM; Azzazy HME; Ibrahim TM
Comput Biol Med; 2021 Jul; 134():104468. PubMed ID: 34015671
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Potential SARS-CoV-2 Papain-like Protease Natural Inhibitors Employing a Multi-Phase In Silico Approach.
Elkaeed EB; Metwaly AM; Alesawy MS; Saleh AM; Alsfouk AA; Eissa IH
Life (Basel); 2022 Sep; 12(9):. PubMed ID: 36143445
[TBL] [Abstract][Full Text] [Related]
15. Potential of turmeric-derived compounds against RNA-dependent RNA polymerase of SARS-CoV-2: An in-silico approach.
Singh R; Bhardwaj VK; Purohit R
Comput Biol Med; 2021 Dec; 139():104965. PubMed ID: 34717229
[TBL] [Abstract][Full Text] [Related]
16. Remdesivir analog as SARS-CoV-2 polymerase inhibitor: virtual screening of a database generated by scaffold replacement.
Said MA; Albohy A; Abdelrahman MA; Ibarhim HS
RSC Adv; 2022 Aug; 12(35):22448-22457. PubMed ID: 36105996
[TBL] [Abstract][Full Text] [Related]
17. Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp).
Bibi S; Hasan MM; Wang YB; Papadakos SP; Yu H
Curr Med Chem; 2022; 29(1):152-162. PubMed ID: 34420502
[TBL] [Abstract][Full Text] [Related]
18. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
19. Teriflunomide: A possible effective drug for the comprehensive treatment of COVID-19.
Rabie AM
Curr Res Pharmacol Drug Discov; 2021; 2():100055. PubMed ID: 34870153
[TBL] [Abstract][Full Text] [Related]
20. Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of
Mir SA; Firoz A; Alaidarous M; Alshehri B; Bin Dukhyil AA; Banawas S; Alsagaby SA; Alturaiki W; Bhat GA; Kashoo F; Abdel-Hadi AM
Saudi J Biol Sci; 2022 Jan; 29(1):394-401. PubMed ID: 34518755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
